The emerging therapy of tirzepatide peptide represents a significant breakthrough in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – GLP-1 and GIP – providing https://tirzepatide-peptide742045.dailyblogzz.com/42560337/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment